Beyond Cystic Fibrosis: Recognising Shwachman-Diamond Syndrome in the Respiratory Clinic. [PDF]
Yang F +3 more
europepmc +1 more source
Tumor suppressor Tsc1 is a new Hsp90 co‐chaperone that facilitates folding of kinase and non‐kinase clients [PDF]
et al, +3 more
core +1 more source
Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. [PDF]
Manioudaki S +11 more
europepmc +1 more source
Distribution of cystic fibrosis patients not eligible to studied CFTR modulators in Europe
Anna Zolin +4 more
openalex +1 more source
Citrus Flavonoids for Cystic Fibrosis Treatment. [PDF]
Pagliaro M +5 more
europepmc +1 more source
Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis. [PDF]
Blankenship S +6 more
europepmc +1 more source
Comparative efficacy and safety of CFTR modulators for people with cystic fibrosis with phe508del mutation: a systematic review and bayesian network meta-analysis. [PDF]
Safeer V S M +7 more
europepmc +1 more source
Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis. [PDF]
Fraquelli M +5 more
europepmc +1 more source
Pulmonary Ionocytes at the Crossroads of Absorption and Secretion: Clues from the Ferret. [PDF]
Gentzsch M.
europepmc +1 more source
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk. [PDF]
Shugg T +9 more
europepmc +1 more source

